Behavioral and electrophysiological analysis of the choline-positive effect of nootropic dipeptide acylproline (GVS-111)
R. U. Ostrovskaya et al. · 2001 · Eksp Klin Farmakol. 64(2):11–14
What does this source report?
Behavioral and electrophysiological findings suggested involvement of muscarinic and nicotinic signaling in the response to GVS-111.
- Population and setting
- Animal learning models and isolated Helix snail neurons
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- See original publication
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Mixed animal and isolated-neuron experiments; no human cholinergic mechanism demonstrated.
- These findings do not support personal supplement combinations.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed primary-paper record and abstract checked; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: R. U. Ostrovskaya et al.. Behavioral and electrophysiological analysis of the choline-positive effect of nootropic dipeptide acylproline (GVS-111) Eksp Klin Farmakol. 64(2):11–14 2001.
Molekul research summary: https://molekul.io/research/noopept-choline-2001. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry